These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23479704)

  • 1. SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretation.
    Glazer DI; Brown RK; Wong KK; Savas H; Gross MD; Avram AM
    Radiographics; 2013; 33(2):397-418. PubMed ID: 23479704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
    Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
    Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer.
    Chudgar AV; Shah JC
    Radiographics; 2017; 37(1):298-315. PubMed ID: 28076008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
    Steffen IG; Mehl S; Heuck F; Elgeti F; Furth C; Amthauer H; Ruf J
    Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal metastases from follicular thyroid cancer on SPECT/CT.
    von Falck C; Beer G; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Sep; 32(9):751-2. PubMed ID: 17710039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
    Ingui CJ; Shah NP; Oates ME
    Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification.
    Avram AM
    J Nucl Med Technol; 2014 Sep; 42(3):170-80. PubMed ID: 25190758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
    Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT/CT characterization of oral activity on radioiodine scintigraphy.
    Savas H; Wong KK; Saglik B; Hubers D; Ackermann RJ; Avram AM
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4410-6. PubMed ID: 24001748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma.
    Ruf J; Lehmkuhl L; Bertram H; Sandrock D; Amthauer H; Humplik B; Ludwig Munz D; Felix R
    Nucl Med Commun; 2004 Dec; 25(12):1177-82. PubMed ID: 15640775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT.
    Ruf J; Steffen I; Mehl S; Rosner C; Denecke T; Pape UF; Plotkin M; Amthauer H
    Nucl Med Commun; 2007 Oct; 28(10):782-8. PubMed ID: 17728608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer.
    Sriprapaporn J; Sethanandha C; Yingsa-nga T; Komoltri C; Thongpraparn T; Harnnanthawiwai C
    J Med Assoc Thai; 2015 Jun; 98(6):596-605. PubMed ID: 26219165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET.
    Fricke E; Fricke H; Weise R; Kammeier A; Hagedorn R; Lotz N; Lindner O; Tschoepe D; Burchert W
    J Nucl Med; 2005 May; 46(5):736-44. PubMed ID: 15872344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
    Pérault C; Schvartz C; Wampach H; Liehn JC; Delisle MJ
    J Nucl Med; 1997 Aug; 38(8):1234-42. PubMed ID: 9255157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
    Schillaci O
    Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
    Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
    AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.